Femodene: Overview

RSS
Modified on 2009/10/14 21:46 by admin
Women taking "third-generation" oral contraceptives such as Femodene, face an increased risk of developing deadly blood clots. These clots, commonly known as deep vein thrombosis (DVT) or venous thromboembolism, develop in the deep veins of the legs or pelvis and can be deadly if they break free and block blood flow into the lungs.

The debate over the connection between third-generation contraceptives and DVT began in 1995 when researchers first warned of the correlation. Recently, Dutch scientists combined the results of 114 studies conducted over the past 6 years and confirmed a relationship between DVT and administration of third-generation contraceptives.

Doctors recommend that women currently taking Femodene, ED, Triadene, Minulet, Tri-minulet, Marvelon or Mercilon, consult with their healthcare provider.

Third generation contraceptives contain the hormones desogestrel or gestodene. Researchers believe that these hormones increase the risk of DVT.

See your doctor if you have experienced serious health problems after taking Femodene. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.



See Also

  1. Pregnancy & Female Reproduction Drugs: Overview
  2. Blood Clots
  3. Deep Vein Thrombosis
  4. Paralysis: Overview
  5. Pulmonary Embolism: Overview
  6. Stroke
  Name Size